Clinical trials: Pericapsular Nerve Group Block (PENG Block)

PENG Block

Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Pericapsular Nerve Group Block in Hip Replacement Surgeries

• Not yet recruiting
• Age: 18 to 90 years
• Phase 2
• Medical device
• Surgery or procedure

Our aim will be to investigate the efficacy of dexmedetomidine as an adjuvant to bupivacaine in ultrasound guided pericapsular nerve group (PENG) block for postoperative analgesia in hip replacement surgeries.

Trial name

NCT06736392

Testing

Ultrasound guided Pericapsular Nerve Group Block, Isobaric Bupivacaine 0. 25%, 20 ml isobaric bupivacaine 0.25% and 1.5μg/kg dexmedetomidine

Volunteers

60 people

Sponsor

Assiut University